WHO 2016 classification: changes and advancements in the diagnosis of miscellaneous primary CNS tumours
This short review highlights significant changes and recent findings incorporated to varying extent in the WHO 2016 definition of a variety of tumours, including peripheral nerve sheath tumours, meningiomas, mesenchymal nonmeningothelial tumours, melanocytic tumours, lymphomas and histiocytic tumour...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2018
|
| In: |
Neuropathology & applied neurobiology
Year: 2017, Jahrgang: 44, Heft: 2, Pages: 163-171 |
| ISSN: | 1365-2990 |
| DOI: | 10.1111/nan.12397 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.1111/nan.12397 Verlag, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/nan.12397 
|
| Verfasserangaben: | F. Sahm, D.E. Reuss and C. Giannini |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1665454377 | ||
| 003 | DE-627 | ||
| 005 | 20230426084909.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190514r20182017xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/nan.12397 |2 doi | |
| 035 | |a (DE-627)1665454377 | ||
| 035 | |a (DE-599)KXP1665454377 | ||
| 035 | |a (OCoLC)1341220171 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Sahm, Felix |d 1984- |e VerfasserIn |0 (DE-588)1022852132 |0 (DE-627)717318478 |0 (DE-576)366075020 |4 aut | |
| 245 | 1 | 0 | |a WHO 2016 classification |b changes and advancements in the diagnosis of miscellaneous primary CNS tumours |c F. Sahm, D.E. Reuss and C. Giannini |
| 264 | 1 | |c 2018 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a First published: 12 March 2017 | ||
| 500 | |a Gesehen am 14.05.2019 | ||
| 520 | |a This short review highlights significant changes and recent findings incorporated to varying extent in the WHO 2016 definition of a variety of tumours, including peripheral nerve sheath tumours, meningiomas, mesenchymal nonmeningothelial tumours, melanocytic tumours, lymphomas and histiocytic tumours, germ cell tumours and non-neuroendocrine pituitary tumours. Most notable classification changes include: adding ‘hybrid nerve sheath tumours’ to the spectrum of benign nerve sheath tumours; an updated definition of atypical meningioma (WHO grade II), including cases with brain invasion; recognizing dural solitary fibrous tumour (SFT) and haemangiopericytoma (HPC) as a single tumour entity characterized by NAB2 and STAT6 gene fusions for which the term SFT/HPC was chosen; recognizing that pituitary granular cell tumour, spindle cell oncocytoma, and pituicytoma all share nuclear expression of TTF-1, possibly representing a spectrum of a single nosological entity derived from posterior pituitary glial cells. The most significant diagnostic markers which have emerged include: inactivation of NF1, CDKN2A, and PRC2 components, SUZ12 and EED in MPNST, leading to neurofibromin and H3K27me3 expression loss; GNAQ and GNA11 mutations in CNS primary melanocytic tumours; BRAFV600E mutation in histiocytic tumours (Langerhans cell histiocytosis and Erdheim-Chester disease) and papillary craniopharyngioma, which provides both a diagnostic marker in the appropriate pathological setting and a therapeutic target. The WHO 2016 Classification has balanced cutting-edge knowledge on the molecular characteristics of the miscellaneous CNS tumours reviewed here with a practical approach for their daily diagnostic work-up. Much more progress can be expected in the classification of these neoplasms in the near future. | ||
| 534 | |c 2017 | ||
| 650 | 4 | |a craniopharyngioma | |
| 650 | 4 | |a histiocytosis | |
| 650 | 4 | |a melanocytic tumours | |
| 650 | 4 | |a meningioma | |
| 650 | 4 | |a peripheral nerve sheath tumours | |
| 650 | 4 | |a pituitary tumours | |
| 650 | 4 | |a solitary fibrous tumour/haemangiopericytoma | |
| 650 | 4 | |a WHO classification | |
| 700 | 1 | |a Reuss, David |d 1976- |e VerfasserIn |0 (DE-588)143839837 |0 (DE-627)655107894 |0 (DE-576)339294337 |4 aut | |
| 700 | 1 | |a Giannini, Caterina |e VerfasserIn |0 (DE-588)1186096802 |0 (DE-627)1665454148 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Neuropathology & applied neurobiology |d Oxford [u.a.] : Wiley-Blackwell, 1975 |g 44(2018), 2, Seite 163-171 |h Online-Ressource |w (DE-627)32046914X |w (DE-600)2008293-9 |w (DE-576)091169585 |x 1365-2990 |7 nnas |a WHO 2016 classification changes and advancements in the diagnosis of miscellaneous primary CNS tumours |
| 773 | 1 | 8 | |g volume:44 |g year:2018 |g number:2 |g pages:163-171 |g extent:9 |a WHO 2016 classification changes and advancements in the diagnosis of miscellaneous primary CNS tumours |
| 856 | 4 | 0 | |u https://doi.org/10.1111/nan.12397 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1111/nan.12397 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20190514 | ||
| 993 | |a Article | ||
| 994 | |a 2018 | ||
| 998 | |g 143839837 |a Reuss, David |m 143839837:Reuss, David |d 910000 |d 912000 |e 910000PR143839837 |e 912000PR143839837 |k 0/910000/ |k 1/910000/912000/ |p 2 | ||
| 998 | |g 1022852132 |a Sahm, Felix |m 1022852132:Sahm, Felix |d 910000 |d 912000 |e 910000PS1022852132 |e 912000PS1022852132 |k 0/910000/ |k 1/910000/912000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1665454377 |e 3475768399 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["F. Sahm, D.E. Reuss and C. Giannini"]},"id":{"eki":["1665454377"],"doi":["10.1111/nan.12397"]},"physDesc":[{"extent":"9 S."}],"recId":"1665454377","origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"2018"}],"person":[{"display":"Sahm, Felix","family":"Sahm","role":"aut","given":"Felix"},{"given":"David","role":"aut","family":"Reuss","display":"Reuss, David"},{"display":"Giannini, Caterina","family":"Giannini","role":"aut","given":"Caterina"}],"relHost":[{"id":{"issn":["1365-2990"],"eki":["32046914X"],"doi":["10.1111/(ISSN)1365-2990"],"zdb":["2008293-9"]},"part":{"year":"2018","volume":"44","pages":"163-171","issue":"2","extent":"9","text":"44(2018), 2, Seite 163-171"},"corporate":[{"role":"isb","display":"British Neuropathological Society"}],"pubHistory":["1.1975 -"],"titleAlt":[{"title":"Neuropathology and applied neurobiology"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 05.06.08"],"title":[{"title":"Neuropathology & applied neurobiology","title_sort":"Neuropathology & applied neurobiology","subtitle":"journal of the British Neuropathological Society"}],"origin":[{"publisher":"Wiley-Blackwell ; Blackwell Science ; Blackwell","publisherPlace":"Oxford [u.a.] ; Oxford [u.a.] ; Oxford [u.a.]","dateIssuedKey":"1975","dateIssuedDisp":"1975-"}],"disp":"WHO 2016 classification changes and advancements in the diagnosis of miscellaneous primary CNS tumoursNeuropathology & applied neurobiology","physDesc":[{"extent":"Online-Ressource"}],"recId":"32046914X"}],"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["First published: 12 March 2017","Gesehen am 14.05.2019"],"title":[{"title":"WHO 2016 classification","title_sort":"WHO 2016 classification","subtitle":"changes and advancements in the diagnosis of miscellaneous primary CNS tumours"}]} | ||
| SRT | |a SAHMFELIXRWHO2016CLA2018 | ||